HCW Biologics Inc. (NASDAQ: HCWB)
$0.69
+0.0460 ( +7.19% ) 0.8K
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
Market Data
Open
$0.69
Previous close
$0.64
Volume
0.8K
Market cap
$25.01M
Day range
$0.66 - $0.69
52 week range
$0.55 - $2.32
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 11 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
8-k | 8K-related | 11 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
ars/a | Annual reports | 1 | May 20, 2024 |
10-k/a | Quarterly Reports | 84 | May 15, 2024 |
10-q | Quarterly Reports | 50 | May 15, 2024 |
8-k | 8K-related | 13 | May 15, 2024 |